Accelerate Diagnostics (AXDX) Tops Q3 EPS by 2c

Accelerate Diagnostics (NASDAQ: AXDX) reported Q3 EPS of ($0.18), $0.02 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $2.96 million versus the consensus estimate of $3.75 million.

For earnings history and earnings-related data on Accelerate Diagnostics (AXDX) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Jernigan Capital (JCAP) Tops Q2 EPS by 5c
• Lument Finance Trust (LFT) Misses Q2 EPS by 17c